AstraZeneca updates total voting rights count
AstraZeneca PLC has reported an updated share count for voting purposes.
Rhea-AI Filing Summary
AstraZeneca PLC has reported an updated share count for voting purposes. As at 31 May 2026, the company’s issued share capital with voting rights consists of 1,551,009,750 ordinary shares of US$0.25 each. The company holds no shares in treasury, so the total number of voting rights is also 1,551,009,750.
This figure is provided under the UK Financial Conduct Authority’s Disclosure and Transparency Rule 5.6.1 and is intended to help shareholders calculate whether they must notify AstraZeneca and regulators about their holdings or changes in their holdings.
Positive
- None.
Negative
- None.
Key Figures
Total voting rights: 1,551,009,750
Ordinary shares in issue with voting rights: 1,551,009,750 shares
Nominal value per ordinary share: US$0.25
+1 more
4 metrics
Total voting rights
1,551,009,750
Total number of voting rights as at 31 May 2026
Ordinary shares in issue with voting rights
1,551,009,750 shares
Issued share capital of US$0.25 ordinary shares as at 31 May 2026
Nominal value per ordinary share
US$0.25
Par value of each AstraZeneca ordinary share
Treasury shares held
0 shares
Treasury position as at 31 May 2026
Key Terms
Total Voting Rights, Disclosure and Transparency Rule 5.6.1, issued share capital, Treasury, +1 more
5 terms
Total Voting Rights financial
"1 June 2026 Total Voting Rights The following notification is made"
The total voting rights number is the count of shares that carry the right to vote at a company’s shareholder meetings, reflecting how much voting power exists in the market. Investors use it to understand control and influence—like knowing how many votes are in play when measuring ownership stakes, calculating a shareholder’s voting percentage, or assessing how easy it would be for a holder to sway decisions.
Disclosure and Transparency Rule 5.6.1 regulatory
"made in accordance with the Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1"
Treasury financial
"No shares are held in Treasury."
The treasury is the department or area within a government or organization responsible for managing its money, finances, and financial strategies. It handles tasks like collecting revenue, paying bills, and planning for future financial needs, much like a household manages its budget. For investors, understanding the treasury is important because it influences interest rates, government spending, and overall economic stability.
voting rights financial
"Therefore, the total number of voting rights in AstraZeneca PLC is 1,551,009,750."
Voting rights are the ability of shareholders to have a say in important company decisions, like choosing leaders or approving big changes. They matter because they give owners a voice in how the company is run, similar to how voters influence elections, ensuring the company acts in shareholders’ interests.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What total voting rights did AstraZeneca (AZN) report as of 31 May 2026?
AstraZeneca reported 1,551,009,750 total voting rights as of 31 May 2026. This equals its issued share capital with voting rights and is used by investors for ownership disclosure calculations.
Why is AstraZeneca (AZN) disclosing its total voting rights?
AstraZeneca is disclosing total voting rights to comply with Disclosure and Transparency Rule 5.6.1. Shareholders use this figure as the denominator when assessing whether they must notify their interests or changes in interests.
Who signed the AstraZeneca (AZN) total voting rights notification?
The notification was signed by Matthew Bowden, Company Secretary of AstraZeneca PLC. It was executed on behalf of the company under the requirements of the Securities Exchange Act of 1934.
AI-generated analysis. How Rhea-AI works. Not financial advice.
